Ascvd statin
Pro Research Analysisby 
Searched over 200M research papers for "ascvd statin"
Statin Use for ASCVD Prevention: Insights and Implications
Statin Therapy in ASCVD Prevention
Statins are the cornerstone of both primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD). Their efficacy in reducing low-density lipoprotein cholesterol (LDL-C) and subsequent ASCVD events has been well-documented across various populations and guidelines Melson2023Mortensen2018Mortensen2019. Despite their proven benefits, the utilization and effectiveness of statin therapy can vary significantly due to several factors, including patient compliance, statin resistance, and the presence of side effects Sun2023Virani2019.
Statin Use in Breast Cancer Patients
A study focusing on breast cancer (BC) patients highlighted the importance of managing ASCVD risk factors, including the use of statins. Among BC patients, a significant proportion had indications for statin therapy at the time of cancer diagnosis, yet many were not prescribed these medications. This gap in care suggests an opportunity to improve ASCVD prevention in this population, particularly for primary prevention .
Suboptimal Statin Response and Management
Suboptimal response to statin therapy is a notable challenge in clinical practice. Factors contributing to this include patient non-compliance, analytical issues with LDL-C measurement, and the presence of lipid disorders such as familial hypercholesterolemia. Addressing these issues through a structured algorithm can optimize lipid-lowering therapy and improve ASCVD outcomes .
Combination Therapy with Ezetimibe
For patients who do not achieve LDL-C targets with statin monotherapy, combination therapy with ezetimibe has been shown to be effective. Ezetimibe, when added to statins, provides additional LDL-C lowering and ASCVD risk reduction without significant safety concerns. This combination is particularly useful for patients with statin-associated muscle symptoms or those who cannot tolerate high-intensity statin therapy .
Racial Disparities in Statin Prescription
Racial disparities in statin prescription and ASCVD outcomes persist. Black patients, for instance, are less likely to receive guideline-directed statin intensity (GDSI) compared to White patients, and they experience delays in the initiation of statin therapy. However, when prescribed GDSI, Black patients show a greater relative benefit in stroke prevention compared to White patients, underscoring the need for equitable healthcare practices .
Statin Use in Primary Prevention: Guideline Comparisons
Comparing the five major guidelines for statin use in primary prevention reveals significant differences in recommendations. The American College of Cardiology/American Heart Association (ACC/AHA), National Institute for Health and Care Excellence (NICE), and Canadian Cardiovascular Society (CCS) guidelines tend to recommend statin therapy for a larger proportion of individuals compared to the U.S. Preventive Services Task Force (USPSTF) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines. These differences impact the sensitivity and specificity of ASCVD event prediction and the number needed to treat (NNT) to prevent one ASCVD event Mortensen2018Mortensen2019.
Residual ASCVD Risk in Statin-Treated Adults
Despite statin therapy, a residual risk of ASCVD remains, particularly in high-risk individuals. Factors such as smoking, diabetes, and subclinical atherosclerosis contribute to this residual risk. Identifying and managing these risk factors through more aggressive treatment strategies can further reduce ASCVD events .
Conclusion
Statin therapy remains a critical component in the prevention of ASCVD. However, challenges such as suboptimal response, racial disparities, and residual risk highlight the need for personalized and equitable approaches to statin use. Combination therapies and adherence to guideline recommendations can enhance the effectiveness of statin therapy, ultimately improving cardiovascular outcomes across diverse populations.
Sources and full results
Most relevant research papers on this topic